世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000037167

咽頭がん治療薬の世界市場(2024-2028)

TechNavio

Global Throat Cancer Therapeutics Market 2024-2028

発刊日 2023/12/15

言語英語

体裁PDF/158ページ

ライセンス/価格158ページ

0000037167

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

咽頭がん治療薬市場は2023年から2028年にかけて23億3,000万米ドル、予測期間中のCAGRは7.51%で成長すると予測されます。このレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。

このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。咽頭がん罹患率の増加、タバコ製品の使用の増加、がんのリスク要因の増加などが市場を牽引しています。

調査範囲

  • 市場セグメント
    ➣ タイプ別
      ◇ 咽頭がん
      ◇ 喉頭がん
    ➣ 流通チャネル別
      ◇ オフライン
      ◇ オンライン
    ➣ 地域別
      ◇ 北アメリカ
      ◇ ヨーロッパ
      ◇ アジア
      ◇ 世界のその他の地域

本調査では、今後数年間の咽頭がん治療薬市場の成長を牽引する主な要因として、ベンダーの戦略的提携の拡大を挙げています。また、咽頭がん治療薬の患者支援プログラムの導入増加や強力なパイプラインは、市場の大きな需要につながっています。

咽頭がん治療薬市場に関するレポートは、次の分野をカバーしています。

  • 咽頭がん治療薬市場の規模
  • 咽頭がん治療薬市場の予測
  • 咽頭がん治療薬市場の業界分析

堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されています。

  • 調査企業
    ➣ Adlai Nortye Ltd.
    ➣ Amgen Inc.
    ➣ AstraZeneca Plc
    ➣ Bayer AG
    ➣ Bristol Myers Squibb Co.
    ➣ Celldex Therapeutics Inc.
    ➣ Clinigen Group Plc
    ➣ Eli Lilly and Co.
    ➣ F. Hoffmann La Roche Ltd.
    ➣ Merck KGaA
    ➣ Moderna Inc.
    ➣ Novartis AG, Pfizer Inc.
    ➣ Regeneron Pharmaceuticals Inc.
    ➣ Sanofi SA

また、咽頭がん治療薬市場分析レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。

このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。

レポート詳細

目次

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market by Geography
Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
Exhibit 06: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size
4.1 Global throat cancer therapeutics market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global throat cancer therapeutics market 2018 - 2022 ($ billion)
4.2 Type Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
4.3 Distribution Channel Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type
6.1 Market segments
Exhibit 30: Chart on Type - Market share 2023-2028 (%)
Exhibit 31: Data Table on Type - Market share 2023-2028 (%)
6.2 Comparison by Type
Exhibit 32: Chart on Comparison by Type
Exhibit 33: Data Table on Comparison by Type
6.3 Pharyngeal cancer - Market size and forecast 2023-2028
Exhibit 34: Chart on Pharyngeal cancer - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on Pharyngeal cancer - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on Pharyngeal cancer - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Pharyngeal cancer - Year-over-year growth 2023-2028 (%)
6.4 Laryngeal cancer - Market size and forecast 2023-2028
Exhibit 38: Chart on Laryngeal cancer - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on Laryngeal cancer - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on Laryngeal cancer - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Laryngeal cancer - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Type
Exhibit 42: Market opportunity by Type ($ billion)
Exhibit 43: Data Table on Market opportunity by Type ($ billion)

7 Market Segmentation by Distribution Channel
7.1 Market segments
Exhibit 44: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibit 45: Data Table on Distribution Channel - Market share 2023-2028 (%)
7.2 Comparison by Distribution Channel
Exhibit 46: Chart on Comparison by Distribution Channel
Exhibit 47: Data Table on Comparison by Distribution Channel
7.3 Offline - Market size and forecast 2023-2028
Exhibit 48: Chart on Offline - Market size and forecast 2023-2028 ($ billion)
Exhibit 49: Data Table on Offline - Market size and forecast 2023-2028 ($ billion)
Exhibit 50: Chart on Offline - Year-over-year growth 2023-2028 (%)
Exhibit 51: Data Table on Offline - Year-over-year growth 2023-2028 (%)
7.4 Online - Market size and forecast 2023-2028
Exhibit 52: Chart on Online - Market size and forecast 2023-2028 ($ billion)
Exhibit 53: Data Table on Online - Market size and forecast 2023-2028 ($ billion)
Exhibit 54: Chart on Online - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Online - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Distribution Channel
Exhibit 56: Market opportunity by Distribution Channel ($ billion)
Exhibit 57: Data Table on Market opportunity by Distribution Channel ($ billion)

8 Customer Landscape
8.1 Customer landscape overview
Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 59: Chart on Market share by geography 2023-2028 (%)
Exhibit 60: Data Table on Market share by geography 2023-2028 (%)
9.2 Geographic comparison
Exhibit 61: Chart on Geographic comparison
Exhibit 62: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 63: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 64: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 65: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 66: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 67: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 68: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 India - Market size and forecast 2023-2028
Exhibit 83: Chart on India - Market size and forecast 2023-2028 ($ billion)
Exhibit 84: Data Table on India - Market size and forecast 2023-2028 ($ billion)
Exhibit 85: Chart on India - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on India - Year-over-year growth 2023-2028 (%)
9.9 Hungary - Market size and forecast 2023-2028
Exhibit 87: Chart on Hungary - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on Hungary - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on Hungary - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Hungary - Year-over-year growth 2023-2028 (%)
9.10 Canada - Market size and forecast 2023-2028
Exhibit 91: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.11 Poland - Market size and forecast 2023-2028
Exhibit 95: Chart on Poland - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on Poland - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on Poland - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on Poland - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity by geography
Exhibit 99: Market opportunity by geography ($ billion)
Exhibit 100: Data Tables on Market opportunity by geography ($ billion)

10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 101: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 103: Overview on factors of disruption
11.4 Industry risks
Exhibit 104: Impact of key risks on business

12 Vendor Analysis
12.1 Vendors covered
Exhibit 105: Vendors covered
12.2 Market positioning of vendors
Exhibit 106: Matrix on vendor position and classification
12.3 Adlai Nortye Ltd.
Exhibit 107: Adlai Nortye Ltd. - Overview
Exhibit 108: Adlai Nortye Ltd. - Product / Service
Exhibit 109: Adlai Nortye Ltd. - Key offerings
12.4 Amgen Inc.
Exhibit 110: Amgen Inc. - Overview
Exhibit 111: Amgen Inc. - Product / Service
Exhibit 112: Amgen Inc. - Key offerings
12.5 AstraZeneca Plc
Exhibit 113: AstraZeneca Plc - Overview
Exhibit 114: AstraZeneca Plc - Product / Service
Exhibit 115: AstraZeneca Plc - Key news
Exhibit 116: AstraZeneca Plc - Key offerings
12.6 Bayer AG
Exhibit 117: Bayer AG - Overview
Exhibit 118: Bayer AG - Business segments
Exhibit 119: Bayer AG - Key news
Exhibit 120: Bayer AG - Key offerings
Exhibit 121: Bayer AG - Segment focus
12.7 Bristol Myers Squibb Co.
Exhibit 122: Bristol Myers Squibb Co. - Overview
Exhibit 123: Bristol Myers Squibb Co. - Product / Service
Exhibit 124: Bristol Myers Squibb Co. - Key news
Exhibit 125: Bristol Myers Squibb Co. - Key offerings
12.8 Celldex Therapeutics Inc.
Exhibit 126: Celldex Therapeutics Inc. - Overview
Exhibit 127: Celldex Therapeutics Inc. - Product / Service
Exhibit 128: Celldex Therapeutics Inc. - Key offerings
12.9 Clinigen Group Plc
Exhibit 129: Clinigen Group Plc - Overview
Exhibit 130: Clinigen Group Plc - Product / Service
Exhibit 131: Clinigen Group Plc - Key offerings
12.10 Eli Lilly and Co.
Exhibit 132: Eli Lilly and Co. - Overview
Exhibit 133: Eli Lilly and Co. - Product / Service
Exhibit 134: Eli Lilly and Co. - Key news
Exhibit 135: Eli Lilly and Co. - Key offerings
12.11 F. Hoffmann La Roche Ltd.
Exhibit 136: F. Hoffmann La Roche Ltd. - Overview
Exhibit 137: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 138: F. Hoffmann La Roche Ltd. - Key news
Exhibit 139: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 140: F. Hoffmann La Roche Ltd. - Segment focus
12.12 Merck KGaA
Exhibit 141: Merck KGaA - Overview
Exhibit 142: Merck KGaA - Business segments
Exhibit 143: Merck KGaA - Key news
Exhibit 144: Merck KGaA - Key offerings
Exhibit 145: Merck KGaA - Segment focus
12.13 Moderna Inc
Exhibit 146: Moderna Inc - Overview
Exhibit 147: Moderna Inc - Product / Service
Exhibit 148: Moderna Inc - Key offerings
12.14 Novartis AG
Exhibit 149: Novartis AG - Overview
Exhibit 150: Novartis AG - Business segments
Exhibit 151: Novartis AG - Key offerings
Exhibit 152: Novartis AG - Segment focus
12.15 Pfizer Inc.
Exhibit 153: Pfizer Inc. - Overview
Exhibit 154: Pfizer Inc. - Product / Service
Exhibit 155: Pfizer Inc. - Key news
Exhibit 156: Pfizer Inc. - Key offerings
12.16 Regeneron Pharmaceuticals Inc.
Exhibit 157: Regeneron Pharmaceuticals Inc. - Overview
Exhibit 158: Regeneron Pharmaceuticals Inc. - Product / Service
Exhibit 159: Regeneron Pharmaceuticals Inc. - Key offerings
12.17 Sanofi SA
Exhibit 160: Sanofi SA - Overview
Exhibit 161: Sanofi SA - Business segments
Exhibit 162: Sanofi SA - Key news
Exhibit 163: Sanofi SA - Key offerings
Exhibit 164: Sanofi SA - Segment focus

13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 165: Inclusions checklist
Exhibit 166: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 167: Currency conversion rates for US$
13.4 Research methodology
Exhibit 168: Research methodology
Exhibit 169: Validation techniques employed for market sizing
Exhibit 170: Information sources
13.5 List of abbreviations
Exhibit 171: List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global throat cancer therapeutics market 2018 - 2022 ($ billion)
Exhibits19: Historic Market Size - Type Segment 2018 - 2022 ($ billion)
Exhibits20: Historic Market Size - Distribution Channel Segment 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Type - Market share 2023-2028 (%)
Exhibits31: Data Table on Type - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Pharyngeal cancer - Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Pharyngeal cancer - Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Pharyngeal cancer - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Pharyngeal cancer - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Laryngeal cancer - Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Laryngeal cancer - Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Laryngeal cancer - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Laryngeal cancer - Year-over-year growth 2023-2028 (%)
Exhibits42: Market opportunity by Type ($ billion)
Exhibits43: Data Table on Market opportunity by Type ($ billion)
Exhibits44: Chart on Distribution Channel - Market share 2023-2028 (%)
Exhibits45: Data Table on Distribution Channel - Market share 2023-2028 (%)
Exhibits46: Chart on Comparison by Distribution Channel
Exhibits47: Data Table on Comparison by Distribution Channel
Exhibits48: Chart on Offline - Market size and forecast 2023-2028 ($ billion)
Exhibits49: Data Table on Offline - Market size and forecast 2023-2028 ($ billion)
Exhibits50: Chart on Offline - Year-over-year growth 2023-2028 (%)
Exhibits51: Data Table on Offline - Year-over-year growth 2023-2028 (%)
Exhibits52: Chart on Online - Market size and forecast 2023-2028 ($ billion)
Exhibits53: Data Table on Online - Market size and forecast 2023-2028 ($ billion)
Exhibits54: Chart on Online - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Online - Year-over-year growth 2023-2028 (%)
Exhibits56: Market opportunity by Distribution Channel ($ billion)
Exhibits57: Data Table on Market opportunity by Distribution Channel ($ billion)
Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits59: Chart on Market share by geography 2023-2028 (%)
Exhibits60: Data Table on Market share by geography 2023-2028 (%)
Exhibits61: Chart on Geographic comparison
Exhibits62: Data Table on Geographic comparison
Exhibits63: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits64: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits65: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits66: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits67: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits68: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits69: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits71: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits72: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits73: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on India - Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on India - Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on India - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on India - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on Hungary - Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on Hungary - Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on Hungary - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on Hungary - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on Poland - Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on Poland - Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on Poland - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on Poland - Year-over-year growth 2023-2028 (%)
Exhibits99: Market opportunity by geography ($ billion)
Exhibits100: Data Tables on Market opportunity by geography ($ billion)
Exhibits101: Impact of drivers and challenges in 2023 and 2028
Exhibits102: Overview on Criticality of inputs and Factors of differentiation
Exhibits103: Overview on factors of disruption
Exhibits104: Impact of key risks on business
Exhibits105: Vendors covered
Exhibits106: Matrix on vendor position and classification
Exhibits107: Adlai Nortye Ltd. - Overview
Exhibits108: Adlai Nortye Ltd. - Product / Service
Exhibits109: Adlai Nortye Ltd. - Key offerings
Exhibits110: Amgen Inc. - Overview
Exhibits111: Amgen Inc. - Product / Service
Exhibits112: Amgen Inc. - Key offerings
Exhibits113: AstraZeneca Plc - Overview
Exhibits114: AstraZeneca Plc - Product / Service
Exhibits115: AstraZeneca Plc - Key news
Exhibits116: AstraZeneca Plc - Key offerings
Exhibits117: Bayer AG - Overview
Exhibits118: Bayer AG - Business segments
Exhibits119: Bayer AG - Key news
Exhibits120: Bayer AG - Key offerings
Exhibits121: Bayer AG - Segment focus
Exhibits122: Bristol Myers Squibb Co. - Overview
Exhibits123: Bristol Myers Squibb Co. - Product / Service
Exhibits124: Bristol Myers Squibb Co. - Key news
Exhibits125: Bristol Myers Squibb Co. - Key offerings
Exhibits126: Celldex Therapeutics Inc. - Overview
Exhibits127: Celldex Therapeutics Inc. - Product / Service
Exhibits128: Celldex Therapeutics Inc. - Key offerings
Exhibits129: Clinigen Group Plc - Overview
Exhibits130: Clinigen Group Plc - Product / Service
Exhibits131: Clinigen Group Plc - Key offerings
Exhibits132: Eli Lilly and Co. - Overview
Exhibits133: Eli Lilly and Co. - Product / Service
Exhibits134: Eli Lilly and Co. - Key news
Exhibits135: Eli Lilly and Co. - Key offerings
Exhibits136: F. Hoffmann La Roche Ltd. - Overview
Exhibits137: F. Hoffmann La Roche Ltd. - Business segments
Exhibits138: F. Hoffmann La Roche Ltd. - Key news
Exhibits139: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits140: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits141: Merck KGaA - Overview
Exhibits142: Merck KGaA - Business segments
Exhibits143: Merck KGaA - Key news
Exhibits144: Merck KGaA - Key offerings
Exhibits145: Merck KGaA - Segment focus
Exhibits146: Moderna Inc - Overview
Exhibits147: Moderna Inc - Product / Service
Exhibits148: Moderna Inc - Key offerings
Exhibits149: Novartis AG - Overview
Exhibits150: Novartis AG - Business segments
Exhibits151: Novartis AG - Key offerings
Exhibits152: Novartis AG - Segment focus
Exhibits153: Pfizer Inc. - Overview
Exhibits154: Pfizer Inc. - Product / Service
Exhibits155: Pfizer Inc. - Key news
Exhibits156: Pfizer Inc. - Key offerings
Exhibits157: Regeneron Pharmaceuticals Inc. - Overview
Exhibits158: Regeneron Pharmaceuticals Inc. - Product / Service
Exhibits159: Regeneron Pharmaceuticals Inc. - Key offerings
Exhibits160: Sanofi SA - Overview
Exhibits161: Sanofi SA - Business segments
Exhibits162: Sanofi SA - Key news
Exhibits163: Sanofi SA - Key offerings
Exhibits164: Sanofi SA - Segment focus
Exhibits165: Inclusions checklist
Exhibits166: Exclusions checklist
Exhibits167: Currency conversion rates for US$
Exhibits168: Research methodology
Exhibits169: Validation techniques employed for market sizing
Exhibits170: Information sources
Exhibits171: List of abbreviations

この商品のレポートナンバー

0000037167

TOP